Pricing

Wegovy Savings Card 2026: Who Qualifies, How to Enroll, and What to Do If It Doesn't Work

Published

Eduard Cristea
Eduard Cristea
Dr. A. Goher, MD
Medically reviewed by Dr. A. Goher, MD
Published:
Quick Answer10 min read

Novo Nordisk's Wegovy Savings Card can drop your cost to as little as $0–$25/month — but only if you have commercial insurance that actually covers Wegovy for weight loss, and roughly half of employer plans don't. If you're on Medicare or Medicaid, federal law blocks the card entirely. Here's exactly who qualifies, how to enroll in 10 minutes, the appeal path when your plan says no, and the cheapest legitimate route to the same semaglutide — $99–$179/month compounded — when the card isn't available to you.

Wegovy Savings Card 2026: Who Qualifies, How to Enroll, and What to Do If It Doesn't Work

Novo Nordisk's Wegovy Savings Card can bring your cost down to as little as $0–$25 per month — but only if you have commercial insurance that actually covers Wegovy for weight management. Roughly half of US employer plans still exclude weight-loss drugs entirely, and if you're on Medicare, Medicaid, or any government plan, federal law bars you from using the card at all. That single "does your plan cover it?" test is what separates the patients who pay $25 from the ones who pay $1,349 — and there's a legitimate $99–$179 path for everyone the card leaves out.

Here's exactly who qualifies in 2026, the four things that disqualify you, how to enroll in about 10 minutes, the appeal path if your plan denies coverage, and the cheapest legitimate route to the same semaglutide molecule when the $25 card isn't available to you.

Who actually qualifies for the Wegovy Savings Card?

Novo Nordisk's official eligibility criteria, as of July 2026:

  • You have commercial (private) insurance — an employer plan or a marketplace plan you bought yourself
  • Your plan covers Wegovy for chronic weight management — this is the requirement most people fail
  • You have a valid Wegovy prescription from a licensed US prescriber (BMI ≥30, or ≥27 with a weight-related condition like high blood pressure, high cholesterol, or type 2 diabetes)
  • You are a US resident age 18+
  • You are NOT enrolled in Medicare, Medicaid, TRICARE, VA, or any other federal or state healthcare program

If you meet all of these, your copay is capped at as low as $0 for a 28-day supply on many covered plans, and no more than $25/month on the rest — for up to 13 fills per year, with an annual maximum benefit Novo currently sets around $3,600.

The one requirement most people fail: does your plan actually cover Wegovy?

This is where the majority of Wegovy searchers get stuck. Unlike Ozempic — a diabetes drug most plans cover — Wegovy is labeled for weight loss, and a large share of US commercial plans still carve out obesity medications completely.

Here's the mechanic that trips people up: the Wegovy Savings Card only lowers your copay after your insurance pays its share. If your plan doesn't cover Wegovy at all, there's no copay to reduce — so the card does almost nothing.

For patients whose commercial plan does NOT cover Wegovy, Novo's card offers a smaller "non-covered" discount that takes the ~$1,349/month retail price down to roughly $650/month. Better than list price, but nowhere near $25 — and still more than three times the price of compounded semaglutide.

To find out in five minutes whether your plan covers it, call the number on the back of your insurance card and ask: "Is Wegovy on my formulary for chronic weight management, and what tier?" If the answer is "not covered" or "excluded," the $25 card is off the table — skip to the cash-pay section below.

Who is excluded — the four disqualifiers

  • Medicare or Medicaid coverage. Federal anti-kickback law prohibits manufacturer savings cards from being applied to any drug paid by Medicare Part D, Medicare Advantage, Medicaid, TRICARE, or the VA. This is firm — there is no workaround, coupon code, or loophole. If you're on Medicare, your 2026 path is the new Medicare GLP-1 Bridge Program at roughly $50/month, not the savings card.
  • Your plan excludes weight-loss drugs. The single most common reason the card fails. If your formulary doesn't list Wegovy for weight management, the card has nothing to discount.
  • No commercial insurance. The card is a copay-reduction layer, not a standalone coupon. Without commercial coverage paying a share, there is no copay for it to lower.
  • No qualifying prescription. You need a documented BMI ≥30 (or ≥27 with a comorbidity). Without a valid Wegovy prescription, the card can't be issued.

How to enroll in the Wegovy Savings Card

Three steps. Total time: about 10 minutes.

  • Go to wegovy.com and click "Save on Wegovy." Novo runs the program through its NovoCare portal.
  • Complete the online form. You'll enter your name, date of birth, ZIP code, and confirm you have commercial insurance and a Wegovy prescription.
  • Save your digital card. You'll receive a card with a Group, BIN, PCN, and Member ID. Present it at the pharmacy with your prescription. Major chains — CVS, Walgreens, Rite Aid, grocery pharmacies — apply it automatically.

The card is reusable across the calendar year, up to 13 fills, and re-verifies your eligibility each January.

What if my insurance won't cover Wegovy? The prior-authorization path

Even when a plan lists Wegovy, it almost always requires prior authorization. Common gates and the fix for each:

  • "Requires prior authorization." Your prescriber submits documentation: BMI, weight history, prior weight-loss attempts, and any comorbidities (hypertension, dyslipidemia, sleep apnea, prediabetes). First-pass approval runs 50–70% with complete records, higher on appeal.
  • "Requires step therapy." The plan wants you to try a lifestyle program or an older, cheaper drug first. If you've already tried and failed those, your prescriber documents it.
  • "Excluded — weight-loss benefit not purchased." Your employer chose a plan without obesity-drug coverage. Appeals rarely reverse this; your realistic options are cash-pay compounded semaglutide or, if you have type 2 diabetes, switching to the Ozempic Savings Card path (same molecule, $25/mo on a diabetes diagnosis).

Telehealth programs that handle prior authorization in-house — worth it when your plan is fighting you:

  • Ro — prescribes brand-name Wegovy and files prior auths directly with your insurer. Cleaner insurance path, higher monthly cost than compounded.
  • TrimRx — doctor consultations include insurance navigation, plus a low-cost compounded fallback if coverage is denied.

For the full ranking of providers by insurance-navigation track record, see our best GLP-1 telehealth programs list.

What if I can't get the $25 card? The cheapest legitimate paths in 2026

If the Wegovy Savings Card is off the table — no coverage, Medicare/Medicaid, or no insurance — these are the real cheapest routes to the same semaglutide molecule, ranked by monthly cost:

PathMonthly costInsurance needed?
Compounded semaglutide — Embody$99/moNo
Compounded semaglutide — Yucca Health$146/moNo
Compounded semaglutide — TrimRx (Editor's Choice)$179/moNo
NovoCare self-pay (brand Wegovy)~$499/moNo
Wegovy Savings Card (non-covered discount)~$650/moCommercial, non-covering
Wegovy retail cash price~$1,349/moNone

Compounded semaglutide is the same active molecule as Wegovy — semaglutide — prescribed by US-licensed telehealth doctors and dispensed by US compounding pharmacies. It requires no insurance and no prior authorization, which is why it's the default cash-pay answer for the roughly half of weight-loss patients whose plans exclude Wegovy. The tradeoffs, and how to screen for a legitimate LegitScript-certified provider, are in our is compounded semaglutide safe guide.

Our current top-rated pick for a clean cash-pay semaglutide program is TrimRx — US-licensed prescribers, transparent pricing from $179/month, and dose-management support built in. If price is your single deciding factor, Embody is the market floor at $99/month.

On Medicare? The savings card won't work — here's your path

If you're on Medicare Part D or Medicare Advantage, the Wegovy Savings Card is legally closed to you, no matter how your plan covers weight-loss drugs. Your 2026 options:

  • Medicare GLP-1 Bridge Program (~$50/month) — CMS's Balance Model, launched July 1, 2026, caps copays for qualifying Part D patients. Approval requires prior authorization that can take weeks. Full walkthrough in our Medicare GLP-1 Bridge guide.
  • Cash-pay compounded semaglutide ($99–$179/month) — available regardless of your Medicare status, because you're paying out of pocket rather than billing the government. This is the immediate path if you don't qualify for the Bridge or don't want to wait on prior authorization.

Frequently asked questions

Is the Wegovy Savings Card really $0 a month? For some patients, yes — on commercial plans that cover Wegovy at a low copay tier, the card can bring your out-of-pocket to $0 for a 28-day supply. On other covered plans it lands at $25/month. The $0/$25 figures only apply when your plan actually covers Wegovy.

Does the Wegovy card work without insurance? No. It's a copay-reduction layer on top of commercial insurance. Without commercial coverage, the card does nothing meaningful — you'd pay the ~$1,349/month retail price. Cash-pay compounded semaglutide ($99–$179/month) is the realistic uninsured path.

Can I use the Wegovy Savings Card with Medicare? No. Federal law prohibits manufacturer copay cards on any Medicare-paid drug. Use the Medicare Bridge Program instead.

My plan doesn't cover Wegovy — is there any version of the card that helps? Novo offers a smaller non-covered discount that brings the price to roughly $650/month. That's still far above compounded semaglutide at $99–$179/month, so most non-covered patients go cash-pay compounded instead.

What's the difference between the Wegovy Savings Card and a GoodRx coupon? They're not the same. GoodRx pricing on brand Wegovy still runs around $1,300/month — a cash discount, not Novo's copay card. The $0/$25 figure refers only to Novo's official savings card layered on commercial insurance.

Can I use the card if I have type 2 diabetes? Wegovy is a weight-management drug, so its card follows weight-management coverage rules. If you have type 2 diabetes, you may qualify for the Ozempic Savings Card instead — same semaglutide molecule, $25/month on a diabetes diagnosis — which is often an easier coverage path.

How long does the Wegovy Savings Card last? Up to 13 fills per calendar year, re-verified each January while you remain eligible.

Bottom line

The Wegovy Savings Card is real, easy to enroll in, and can genuinely get you to $0–$25/month — if you have commercial insurance that covers Wegovy for weight management. For patients who clear that bar, apply the card and you're done.

For everyone else — the roughly half of weight-loss patients whose plans exclude obesity drugs, plus everyone on Medicare, Medicaid, or no insurance — the $25 headline is a mirage. The honest cheapest path to the same semaglutide molecule in 2026 is compounded semaglutide through a verified telehealth provider: Embody at $99/month, Yucca Health at $146/month, or our top-rated TrimRx at $179/month — no insurance, no prior authorization, shipped to your door.

Start by comparing every verified program side by side on our best GLP-1 providers list.

Ready to start?

TrimRx is our top-rated pick — GLP-1 from $179/mo, delivered. Or compare all 34 programs first.

See TrimRx — from $179/mo →

Related Posts